226 related articles for article (PubMed ID: 8027255)
1. A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion.
Lewis GF; Steiner G; Polonsky KS; Weller B; Zinman B
J Clin Endocrinol Metab; 1994 Jul; 79(1):66-70. PubMed ID: 8027255
[TBL] [Abstract][Full Text] [Related]
2. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans.
Lewis GF; Zinman B; Groenewoud Y; Vranic M; Giacca A
Diabetes; 1996 Apr; 45(4):454-62. PubMed ID: 8603767
[TBL] [Abstract][Full Text] [Related]
3. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.
Lewis GF; Carpentier A; Vranic M; Giacca A
Diabetes; 1999 Mar; 48(3):570-6. PubMed ID: 10078558
[TBL] [Abstract][Full Text] [Related]
4. Counterregulatory response to hypoglycemia differs according to the insulin delivery route, but does not affect glucose production in normal humans.
Lewis GF; Carpentier A; Bilinski D; Giacca A; Vranic M
J Clin Endocrinol Metab; 1999 Mar; 84(3):1037-46. PubMed ID: 10084592
[TBL] [Abstract][Full Text] [Related]
5. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.
Lewis GF; Vranic M; Harley P; Giacca A
Diabetes; 1997 Jul; 46(7):1111-9. PubMed ID: 9200644
[TBL] [Abstract][Full Text] [Related]
6. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.
Banarer S; McGregor VP; Cryer PE
Diabetes; 2002 Apr; 51(4):958-65. PubMed ID: 11916913
[TBL] [Abstract][Full Text] [Related]
7. VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin.
Lewis GF; Zinman B; Uffelman KD; Szeto L; Weller B; Steiner G
Am J Physiol; 1994 Oct; 267(4 Pt 1):E566-72. PubMed ID: 7943306
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: selective amplification of insulin secretory burst mass.
Pørksen NK; Munn SR; Steers JL; Schmitz O; Veldhuis JD; Butler PC
Diabetes; 1996 Dec; 45(12):1792-7. PubMed ID: 8922367
[TBL] [Abstract][Full Text] [Related]
9. Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
Peacey SR; George E; Rostami-Hodjegan A; Bedford C; Harris N; Hardisty CA; Tucker GT; Macdonald IA; Heller SR
Diabet Med; 1996 Jul; 13(7):634-41. PubMed ID: 8840097
[TBL] [Abstract][Full Text] [Related]
10. The effect of portal and peripheral insulin delivery on carbohydrate and lipid metabolism in a miniature pig model of human IDDM.
Canavan JP; Flecknell PA; New JP; Alberti KG; Home PD
Diabetologia; 1997 Oct; 40(10):1125-34. PubMed ID: 9349592
[TBL] [Abstract][Full Text] [Related]
11. Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans.
Lewis GF; Vranic M; Giacca A
Am J Physiol; 1997 Mar; 272(3 Pt 1):E371-8. PubMed ID: 9124541
[TBL] [Abstract][Full Text] [Related]
12. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
[TBL] [Abstract][Full Text] [Related]
13. Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia.
Ryan AS; Egan JM; Habener JF; Elahi D
J Clin Endocrinol Metab; 1998 Jul; 83(7):2399-404. PubMed ID: 9661618
[TBL] [Abstract][Full Text] [Related]
14. Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans.
Lewis GF; Vranic M; Giacca A
Am J Physiol; 1998 Jul; 275(1):E177-86. PubMed ID: 9688888
[TBL] [Abstract][Full Text] [Related]
15. Symptoms, hormones, and glucose fluxes during a gradual hypoglycaemia induced by intraperitoneal vs venous insulin infusion in Type I diabetes.
Selam JL; Medlej R; M'bemba J; Chevalier A; Guyon F; Ashworth L; Slama G
Diabet Med; 1995 Dec; 12(12):1102-9. PubMed ID: 8750221
[TBL] [Abstract][Full Text] [Related]
16. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
17. Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans.
Meier JJ; Veldhuis JD; Butler PC
Diabetes; 2005 Jun; 54(6):1649-56. PubMed ID: 15919785
[TBL] [Abstract][Full Text] [Related]
18. The effect of tolbutamide and hepatic extraction of insulin and glucagon and hepatic glucose output in anesthetized dogs.
Ishida T; Chou MC; Lewis RM; Hartley CJ; Entman M; Field JB
Endocrinology; 1981 Aug; 109(2):443-50. PubMed ID: 7018888
[TBL] [Abstract][Full Text] [Related]
19. Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes.
Israelian Z; Gosmanov NR; Szoke E; Schorr M; Bokhari S; Cryer PE; Gerich JE; Meyer C
Diabetes Care; 2005 Nov; 28(11):2691-6. PubMed ID: 16249541
[TBL] [Abstract][Full Text] [Related]
20. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
Polonsky KS; Licinio-Paixao J; Given BD; Pugh W; Rue P; Galloway J; Karrison T; Frank B
J Clin Invest; 1986 Jan; 77(1):98-105. PubMed ID: 3511094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
